temozolomide has been researched along with sesquiterpenes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Devineni, D; Gallo, JM; Klein-Szanto, A | 1 |
| Chu, J; Gallo, JM; Li, S; Ma, J; Pulfer, S; Reed, K | 1 |
| Bookman, MA; Gallo, JM; Guo, P; Li, S; Ma, J; Orlansky, A; Pulfer, S; Vicini, P; Zhou, F | 1 |
| Gao, X; Li, XM; Li, ZQ; Liang, GB; Luo, LH; Song, ZQ; Su, JY; Zhu, TZ | 1 |
| Cao, P; Li, XM; Liang, GB; Liu, Y; Luo, LH; Xu, YH; Zhu, TZ | 1 |
| Ge, N; Gong, A; Liang, H; Lu, L; Yao, W | 1 |
| Liu, S; Yuan, Y; Zhao, Y; Zhou, L | 1 |
| Chen, BD; Chen, L; Li, QZ; Li, WP; Li, ZY; Zhang, C; Zhang, XJ | 1 |
| Chen, FR; Chen, ZP; Feng, HB; Guo, CC; Jiang, HR; Mei, X; Qu, Y; Sai, K; Wang, J; Yang, QY; Zhang, ZP; Zhao, YY | 1 |
| Glumac, M; Jakimov, D; Kojic, V; Pejin, B; Tommonaro, G | 1 |
| Chen, Y; Li, P; Wang, S; Yu, Z; Yuan, Y; Zhou, G | 1 |
| Chen, L; Huang, GD; Li, WP; Li, ZY; Liu, WL; Liu, YC; Xu, J; Zhang, Y; Zheng, YY | 1 |
| Chai, Z; Li, J; Lu, L; Lu, W; Mao, J; Ran, D; Wu, S; Xie, C; Zhan, C; Zhang, Y; Zhou, J | 1 |
| Fan, C; Hu, L; Lv, X; Qian, Y; Sun, J; Tian, N | 1 |
14 other study(ies) available for temozolomide and sesquiterpenes
| Article | Year |
|---|---|
Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cyclohexanes; Dacarbazine; Factor VIII; Glioma; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Rats; Sesquiterpenes; Temozolomide; Tumor Cells, Cultured | 1996 |
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Cyclohexanes; Dacarbazine; Dialysis Solutions; Drug Interactions; Humans; Male; Microdialysis; Neoplasms, Experimental; O-(Chloroacetylcarbamoyl)fumagillol; Rats; Rats, Nude; Sesquiterpenes; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Pharmacokinetic model-predicted anticancer drug concentrations in human tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Computer Simulation; Cyclohexanes; Dacarbazine; Female; Humans; Male; Models, Biological; O-(Chloroacetylcarbamoyl)fumagillol; Ovarian Neoplasms; Predictive Value of Tests; Rats; Rats, Inbred F344; Rats, Nude; Sesquiterpenes; Temozolomide; Topotecan; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2004 |
β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Blotting, Western; Cell Differentiation; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Glioblastoma; Glycoproteins; Heterografts; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Peptides; Sesquiterpenes; Temozolomide | 2014 |
β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcuma; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Flavonoids; Glia Maturation Factor; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Survivin; Temozolomide | 2014 |
Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hydrocarbons, Brominated; Male; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; MicroRNAs; Sesquiterpenes; Temozolomide; Xenograft Model Antitumor Assays | 2014 |
β-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; DNA Repair; Drug Synergism; Glioblastoma; Humans; Radiation-Sensitizing Agents; Rats; Sesquiterpenes; Temozolomide | 2015 |
Radicol, a Novel Trinorguaiane-Type Sesquiterpene, Induces Temozolomide-Resistant Glioma Cell Apoptosis via ER Stress and Akt/mTOR Pathway Blockade.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; Dictamnus; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Glioblastoma; Glioma; Glycogen Synthase Kinase 3; Humans; In Situ Nick-End Labeling; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sesquiterpenes; Temozolomide; TOR Serine-Threonine Kinases | 2017 |
β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Down-Regulation; Drug Synergism; Glioma; Humans; Male; Mice, Nude; Neoplastic Stem Cells; Receptor, Notch1; Sesquiterpenes; Spheroids, Cellular; Temozolomide | 2017 |
The redox couple avarol/avarone in the fight with malignant gliomas: the case study of U-251 MG cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Comet Assay; Cyclohexenes; Dacarbazine; DNA Damage; Doxorubicin; Fibroblasts; Glioma; Humans; Oxidation-Reduction; Sesquiterpenes; Temozolomide | 2018 |
Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Mice, SCID; Rats; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Temozolomide; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2018 |
Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
Topics: Adult; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chondroitin Sulfate Proteoglycans; Down-Regulation; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Furans; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MAP Kinase Signaling System; Membrane Proteins; Proto-Oncogene Proteins c-akt; Sesquiterpenes; Signal Transduction; Temozolomide; Transcription, Genetic | 2019 |
All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Endoplasmic Reticulum Chaperone BiP; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Rats, Sprague-Dawley; Sesquiterpenes; Temozolomide | 2020 |
Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Glioma; Humans; RNA, Long Noncoding; Sesquiterpenes; Signal Transduction; Temozolomide | 2021 |